Follow
AegirBio AB
Nasdaq First North Sweden (Sweden)
AegirBio AB is a Swedish diagnostic company that offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. The company's products include Monator - drug monitoring of tysabri in MS, Veritope, and Magniareader.
Sector:
HEALTH CARE
>
Medical Instruments & Supplies
Exercise
Price
9.00 SEK
Exercise period(s)
26 Jun 2020 - 26 Mar 2021
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
AEGIR
SE0014401121
Nasdaq First North Sweden
Sweden (SE)
Details of share in AegirBio AB with ticker AEGIR
Status
Active
Order book id
Amount of instruments
6 860 878
Par value
Market cap
Currency
SEK
Segment
First North
First trading date
26 Jun 2020
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
7.50 SEK
50M SEK
01 Jun - 15 Jun 2020
IPO in AegirBio AB
Type
Ticker
ISIN
Market
OPTION
AEGIR TO1
SE0014428926
Nasdaq First North Sweden
Sweden (SE)
Details of option in AegirBio AB with ticker AEGIR TO1
Status
Active
Order book id
197305
Amount of instruments
2 460 000
Market cap
Currency
SEK
Segment
First North
Trading period
26 Jun 2020 - 24 Mar 2021
Terms
One (1) warrant of series TO1 gives the right to subscribe for one (1) new share in the Company.
Type
Price
Pre-money valuation
Time
Files
Exercise
9.00 SEK
50M SEK
26 Jun 2020 - 26 Mar 2021
Option exercise terms for AEGIR TO1
People
Anders Ingvarsson
Chairman of the board
Martin Linde
Board member
Bradley Messmer
Board member
Company Details
Sector
HEALTH CARE

Address
Sölvegatan 43 A
Zip code
223 70
City/district
Lund
Country
Sweden (SE)
Registration number
5592222953
LEI code
549300MWGS283WZLYI10
First trade date
26 Jun 2020
Registration date
14 Oct 2019
Short name
AegirBio

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date